Search results for: 'Preferred Destination for Early Phase Clinical Trials'

Despite global political uncertainties and a subdued economic outlook, 2019 proves to be promising for the global healthcare industry, supported by growing and more aware middle class, accelerated aging population across the globe seeking personalized medical insurance, and higher R&D budgets across the board. The adoption of digital technologies g...